OLER ABRAHAM N. 4
4 · Onconova Therapeutics, Inc. · Filed Feb 19, 2021
Insider Transaction Report
Form 4
OLER ABRAHAM N.
VP Corp Dev & Gen Counsel
Transactions
- Award
Stock Appreciation Right
2021-02-17+208,000→ 208,000 totalExercise: $1.51Exp: 2031-02-17→ Common Stock (208,000 underlying)
Footnotes (2)
- [F1]These stock appreciation rights vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years.
- [F2]These stock appreciation rights represent the right to receive a cash payment equal to the excess, if any, of (i) the fair market value of each underlying share of the Company's common stock, determined on the date of exercise minus (ii) the exercise price; provided, that in no event may the cash payment for each stock appreciation right exceed $1.03, which is the maximum price per share of $2.54, minus the base amount of $1.51, subject to adjustment in accordance with the terms of the award agreement.